2021
Non-steroidal treatment of cardiac sarcoidosis: A systematic review
Gallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, Miller EJ. Non-steroidal treatment of cardiac sarcoidosis: A systematic review. IJC Heart & Vasculature 2021, 34: 100782. PMID: 33997256, PMCID: PMC8105294, DOI: 10.1016/j.ijcha.2021.100782.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNon-steroidal treatmentSteroid-sparing agentCardiac sarcoidosisSafety profileSystematic reviewCases of CSDisease-modifying antirheumatic agentsManagement of CSActive cardiac sarcoidosisAnti-inflammatory managementAverage corticosteroid doseHigher-line treatmentsMaintenance steroid doseFirst-line treatmentSide effect profileSteroid-sparing therapiesInception of databasesLong-term useCorticosteroid doseSteroid doseBiologic DMARDsImmunosuppressive therapyTreatment initiationEffect profileImmunosuppressive agents
2015
Multimodality Imaging of Cardiac Sarcoidosis
Blankstein R, Miller E. Multimodality Imaging of Cardiac Sarcoidosis. 2015, 51-72. DOI: 10.1007/978-3-319-14624-9_7.ChaptersCardiac sarcoidosisCardiac MRIImaging testsHigh negative predictive valueExtra-cardiac diseasePreferred imaging testLate gadolinium enhancementFuture adverse eventsNegative predictive valueActive myocardial inflammationImmunosuppressive therapyCardiac involvementMyocardial inflammationAdverse eventsExcellent prognosisClinical criteriaReliable reference standardGadolinium enhancementSarcoidosisPredictive valueMultimodality imagingPatientsTherapyMRIDiagnosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply